Neogenomics Inc. (NEO) Investor Alert: Key Takeaways From Their Latest SEC 10-Q Filing
In a challenging landscape, the company faced a decline in Advanced Diagnostics revenue, attributed to site closures and restructuring. Operating expenses surged, reflecting management's focus on efficiency amidst a net...









